Skip to main content
Equibles

Woodline Partners LP

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1784547 San Francisco, CA
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,113,765
+$518,788 QoQ
Shares Held
195,033
0.0% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#74
of 271 holders
Holding Since
Sep 2022
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. ARQT ranks #134 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in ARQT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,113,765 195,033
2026-03-31 $4,594,977 195,033
2025-12-31 $5,663,758 195,033
2025-09-30 $5,930,568 314,619
2025-06-30 $2,881,250 205,510
2025-03-31 $6,412,400 410,000
2023-09-30 $5,863,535 1,104,244
2023-06-30 $7,697,857 807,750
2023-03-31 $7,652,425 695,675
2022-12-31 $9,544,505 644,899
2022-09-30 $10,518,067 550,396